From: Multi-target QSAR modelling in the analysis and design of HIV-HCV co-inhibitors: an in-silico study
Precursor
Structure
pKi
#17 pKi: 9.28
+ 2.11% (× 25.3)
+ 2.04% (× 25.3)
+ 1.95% (× 25.2)